Search engine for discovering works of Art, research articles, and books related to Art and Culture
Javascript must be enabled to continue!
ADT w raku prostaty 2022 – wybór czy konieczność?
View through CrossRef
Rak prostaty jest coraz częściej występującym nowotworem złośliwym. Terapia opiera się na postępowaniu miejscowym (chirurgia, radioterapia) i leczeniu systemowym (hormonoterapia, chemioterapia). Deprywacja androgenowa odgrywa kluczową rolę w leczeniu raka stercza. Różne kombinacje leków pozwalają na coraz dłuższy czas życia pacjentów. W artykule przedstawiono wybrane zagadnienia związane z nowymi możliwościami leczenia w różnych stadiach choroby.
Title: ADT w raku prostaty 2022 – wybór czy konieczność?
Description:
Rak prostaty jest coraz częściej występującym nowotworem złośliwym.
Terapia opiera się na postępowaniu miejscowym (chirurgia, radioterapia) i leczeniu systemowym (hormonoterapia, chemioterapia).
Deprywacja androgenowa odgrywa kluczową rolę w leczeniu raka stercza.
Różne kombinacje leków pozwalają na coraz dłuższy czas życia pacjentów.
W artykule przedstawiono wybrane zagadnienia związane z nowymi możliwościami leczenia w różnych stadiach choroby.
Related Results
Efficacy of Androgen Deprivation Therapy (ADT) in Combination with Radiation Therapy, compared to ADT alone in Patients with High-Risk Prostate Cancer: a meta-analysis
Efficacy of Androgen Deprivation Therapy (ADT) in Combination with Radiation Therapy, compared to ADT alone in Patients with High-Risk Prostate Cancer: a meta-analysis
Abstract
Background
Androgen deprivation therapy (ADT) has long been a cornerstone of treatment for patients with locally advanced or metastatic hormone-sensitive prostate...
Efficacy of androgen deprivation therapy (ADT) in patients with advanced prostate cancer
Efficacy of androgen deprivation therapy (ADT) in patients with advanced prostate cancer
AbstractBACKGROUNDThe purpose of this study was to compare predictive factors for the efficacy of androgen deprivation therapy (ADT) in men with hormone‐sensitive prostate cancer (...
The curative effect of androgen deprivation therapy alone is insufficient in high-risk prostate cancer
The curative effect of androgen deprivation therapy alone is insufficient in high-risk prostate cancer
Abstract
To compare the outcomes of patients with high-risk prostate cancer treated by primary radical prostatectomy (RP) and primary androgen deprivation therapy (ADT)...
Post Hoc Subgroup Analysis of Clinical Outcomes in Patients With High‐Risk Metastatic Hormone‐Naïve Prostate Cancer: Results From a 3‐Year Interim Analysis of the J‐ROCK Study
Post Hoc Subgroup Analysis of Clinical Outcomes in Patients With High‐Risk Metastatic Hormone‐Naïve Prostate Cancer: Results From a 3‐Year Interim Analysis of the J‐ROCK Study
ABSTRACT
Introduction
In real‐world practice in Japan, standard treatment for metastatic hormone‐naïve prostate cancer (m...
Shade netting and reflective mulches effect on yield and quality variables of ‘Gala Baigent’ and ‘Fuji Raku Raku’ apples
Shade netting and reflective mulches effect on yield and quality variables of ‘Gala Baigent’ and ‘Fuji Raku Raku’ apples
ABSTRACT
Sunburn is possibly the main problem affecting the apple production in the Southern Hemisphere including Chile. This study focused on determining the eff...
The Effect of Androgen Deprivation Therapy on the Cardiovascular System in Advanced Prostate Cancer
The Effect of Androgen Deprivation Therapy on the Cardiovascular System in Advanced Prostate Cancer
Androgen deprivation therapy (ADT) is a mainstay treatment for metastatic prostate cancer, improving progression-free survival. ADT suppresses the production of testosterone and re...
Validation of Advanced Dvorak Technique (ADT) over north Indian Ocean
Validation of Advanced Dvorak Technique (ADT) over north Indian Ocean
The Advanced Dvorak Technique (ADT) has been installed in India Meteorological Department experimentally since 2014. There is a need to validate this technique before it’s used ope...
Pituitary-testis axis dysfunction following adjuvant androgen deprivation therapy
Pituitary-testis axis dysfunction following adjuvant androgen deprivation therapy
Men with high-risk, non-metastatic prostate cancer receive adjuvant androgen deprivation therapy (ADT) for at least 2 years according to Danish guidelines. It remains unclarified i...